IDE Antikörper (Internal Region)
-
- Target Alle IDE Antikörper anzeigen
- IDE (Insulin-Degrading Enzyme (IDE))
-
Bindungsspezifität
- Internal Region
-
Reaktivität
- Human, Hund
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser IDE Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- This antibody reacts to Insulysin / Insulinase.
- Kreuzreaktivität (Details)
-
Species reactivity (expected):Canine.
Species reactivity (tested):Human. - Aufreinigung
- Affinity chromatography
- Immunogen
- Peptide with sequence C-QQYNFDRDNTE, from the internal region of the protein sequence
- Top Product
- Discover our top product IDE Primärantikörper
-
anti-Insulin-Degrading Enzyme (IDE) (AA 491-590) antibody
IDE Reaktivität: Human, Maus, Ratte WB, ELISA, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Degrading Enzyme (IDE) (AA 753-973) antibodyIDE Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Degrading Enzyme (IDE) (AA 1-250) antibodyIDE Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Degrading Enzyme (IDE) antibodyIDE Reaktivität: Human WB, IHC (p), IF Wirt: Maus Monoclonal 1H4 unconjugated
anti-Insulin-Degrading Enzyme (IDE) (AA 920-1019) antibodyIDE Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Insulin-Degrading Enzyme (IDE) (N-Term) antibodyIDE Reaktivität: Human, Maus, Ratte WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Degrading Enzyme (IDE) (Internal Region) antibodyVerified IDE Reaktivität: Human WB, ELISA, IHC Wirt: Ziege Polyclonal unconjugated
anti-Insulin-Degrading Enzyme (IDE) antibodyIDE Reaktivität: Human, Maus, Ratte WB, ELISA, IHC (p), FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Insulin-Degrading Enzyme (IDE) (AA 501-800) antibodyIDE Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Peptide ELISA: 1/32000. Western Blot: 0.1 - 0.3 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 0,5 mg/mL
- Buffer
- Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- Target
- IDE (Insulin-Degrading Enzyme (IDE))
- Andere Bezeichnung
- Insulin-Degrading Enzyme (IDE Produkte)
- Hintergrund
- Insulin degrading enzyme (IDE) has a preferential affinity for insulin such that the presence of insulin will inhibit IDE mediated degradation of other substrates. IDE degrades a variety of other peptides including atrial natriuretic peptide and amylin. IDE catabolizes A beta and has been implicated as a candidate enzyme responsible for the degradation and clearance of A beta in the brain. IDE has also been shown to degrade the APP intracellular domain (AICD), a product of gamma secretase cleaved APP that may function in nuclear signaling.Synonyms: Abeta-degrading protease, EC=3.4.24.56, IDE, Insulin protease, Insulinase, Insulysin
- Gen-ID
- 3416, 9606
- UniProt
- P14735
- Pathways
- SARS-CoV-2 Protein Interaktom
-
